| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Procter and Gamble |
| Information provided by: | Procter and Gamble |
| ClinicalTrials.gov Identifier: | NCT00071422 |
Purpose
Insulin is a chemical that the body needs in order to use or store sugar. It is made by a type of cell called a beta cell which resides in an organ known as the pancreas. Type 2 diabetes is a disease where the beta cells are unable to meet a person's insulin needs. Sugar levels rise in the blood as a result. INGAP-Peptide is being tested to attempt to create new beta cells in the pancreas, and to improve the ability to produce insulin in type 2 diabetic patients.
| Condition | Intervention | Phase |
|
Diabetes Mellitus, Non-Insulin-Dependent |
Drug: INGAP-Peptide |
Phase II |
| MedlinePlus related topics: | Diabetes |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Eligibility
| Ages Eligible for Study: | 35 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Contacts and Locations| United States, California | |||||
| Diabetes and Endocrine Associates | |||||
| La Jolla, California, United States, 92037 | |||||
| Diablo Clinical Research | |||||
| Walnut Creek, California, United States, 94598 | |||||
| VA Hospital UCSD | |||||
| San Diego, California, United States, 92161 | |||||
| United States, Colorado | |||||
| Longmont Medical Research Network | |||||
| Longmont, Colorado, United States, 80501 | |||||
| Denver, Colorado, United States, 80209 | |||||
| United States, District of Columbia | |||||
| MedStar Clinical Research Center | |||||
| Washington, District of Columbia, United States, 20003 | |||||
| United States, Massachusetts | |||||
| Future Care Studies | |||||
| Springfield, Massachusetts, United States, 01107 | |||||
| United States, Montana | |||||
| Mercury Street Medical | |||||
| Butte, Montana, United States, 59701 | |||||
| United States, New York | |||||
| Diabetes-Endocrinology Center of WNY | |||||
| Buffalo, New York, United States, 14209 | |||||
| United States, North Carolina | |||||
| Piedmont Medical Group | |||||
| Winston Salem, North Carolina, United States, 27103 | |||||
| UNC Diabetes Care Center | |||||
| Durham, North Carolina, United States, 27713 | |||||
| United States, Oregon | |||||
| Clinical Research Institute of Southern Oregon | |||||
| Medford, Oregon, United States, 97504 | |||||
| United States, South Carolina | |||||
| Mountain View Clinical Research | |||||
| Greer, South Carolina, United States, 29651 | |||||
| United States, Texas | |||||
| Dallas Diabetes and Endocrine Center | |||||
| Dallas, Texas, United States, 75230 | |||||
| DGD Research Associates | |||||
| San Antonio, Texas, United States, 78229 | |||||
| University of Texas Health Science Center - Texas Diabetes Institute | |||||
| San Antonio, Texas, United States, 78207 | |||||
| United States, Virginia | |||||
| Charlottesville Medical Research | |||||
| Charlottesville, Virginia, United States, 22911 | |||||
| Procter and Gamble |
More Information
| Study ID Numbers: | 2003069 |
| First Received: | October 22, 2003 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00071422 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
